Skip Navigation



Human Molecular Genetics Advance Access published online on April 2, 2008

Human Molecular Genetics, doi:10.1093/hmg/ddn095
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
17/13/1978    most recent
ddn095v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Kohler, E. M.
Right arrow Articles by Schneikert, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kohler, E. M.
Right arrow Articles by Schneikert, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Functional definition of the mutation cluster region of adenomatous polyposis coli in colorectal tumours

Eva Maria Kohler1, Adrian Derungs2, Gabriele Daum1, Jürgen Behrens1,* and Jean Schneikert1

1 Nikolaus-Fiebiger-Center for Molecular Medicine, University Erlangen-Nürnberg, Glückstrasse 6, 91054 Erlangen, Germany 2 Department of Internal Medicine Cantonal Hospital St.Gallen, Rorschacher Strasse 95, 9007 St.Gallen, Switzerland

* Corresponding author. jbehrens{at}molmed.uni-erlangen.de Tel: +49-913185-29110 Fax: +49-913185-29111

Received February 5, 2008; Revised March 19, 2008; Accepted March 19, 2008

The mutation cluster region (MCR) of ADENOMATOUS POLYPOSIS COLI (APC) is located within the central part of the open reading frame, overlapping with the region encoding the 20 amino acid repeats (20R) that are β-catenin binding sites. Each mutation in the MCR leads to the synthesis of a truncated APC product expressed in a colorectal tumour. The MCR extends from the 3' border of the first 20R coding region to approximately the middle of the third 20R coding region, reflecting both positive and negative selections of the N- and C-terminal halves of the APC protein in colon cancer cells, respectively. In contrast, the second 20R escapes selection and can be either included or excluded from the truncated APC products found in colon cancer cells. To specify the functional outcome of the selection of the mutations, we investigated the β-catenin binding capacity of the first three 20R in N-terminal APC fragments. We found in co-immunoprecipitation and intracellular co-localization experiments that the second 20R is lacking any β-catenin binding activity. Similarly, we also show that the tumor-associated truncations abolish the interaction of β-catenin with the third 20R. Thus, our data provide a functional definition of the MCR: the APC fragments typical of colon cancer are selected for the presence of a single functional 20R, the first one, and are therefore equivalent relative to β-catenin binding.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum Mol GenetHome page
E. M. Kohler, S. H. V. Chandra, J. Behrens, and J. Schneikert
{beta}-Catenin degradation mediated by the CID domain of APC provides a model for the selection of APC mutations in colorectal, desmoid and duodenal tumours
Hum. Mol. Genet., January 15, 2009; 18(2): 213 - 226.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.